ImmunoGen Correlations
IMGNDelisted Stock | USD 18.20 0.81 4.26% |
The current 90-days correlation between ImmunoGen and Madrigal Pharmaceuticals is 0.06 (i.e., Significant diversification). A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as ImmunoGen moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if ImmunoGen moves in either direction, the perfectly negatively correlated security will move in the opposite direction.
ImmunoGen Correlation With Market
Significant diversification
The correlation between ImmunoGen and DJI is 0.03 (i.e., Significant diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding ImmunoGen and DJI in the same portfolio, assuming nothing else is changed.
ImmunoGen |
Moving together with ImmunoGen Stock
0.92 | T | ATT Inc Aggressive Push | PairCorr |
0.78 | CSCO | Cisco Systems | PairCorr |
0.73 | AA | Alcoa Corp Fiscal Year End 15th of January 2025 | PairCorr |
0.85 | WMT | Walmart Aggressive Push | PairCorr |
0.65 | BAC | Bank of America Aggressive Push | PairCorr |
0.86 | TRV | The Travelers Companies Fiscal Year End 17th of January 2025 | PairCorr |
0.7 | CAT | Caterpillar Fiscal Year End 3rd of February 2025 | PairCorr |
Moving against ImmunoGen Stock
0.78 | VNTN | VentureNet Capital | PairCorr |
0.72 | MRK | Merck Company Fiscal Year End 6th of February 2025 | PairCorr |
0.41 | JNJ | Johnson Johnson Fiscal Year End 28th of January 2025 | PairCorr |
0.35 | PFE | Pfizer Inc Fiscal Year End 4th of February 2025 | PairCorr |
Related Correlations Analysis
Click cells to compare fundamentals | Check Volatility | Backtest Portfolio |
Correlation Matchups
Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.High positive correlations
| High negative correlations
|
Risk-Adjusted Indicators
There is a big difference between ImmunoGen Stock performing well and ImmunoGen Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze ImmunoGen's multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.Mean Deviation | Jensen Alpha | Sortino Ratio | Treynor Ratio | Semi Deviation | Expected Shortfall | Potential Upside | Value @Risk | Maximum Drawdown | ||
---|---|---|---|---|---|---|---|---|---|---|
MDGL | 2.57 | 0.37 | 0.12 | 1.55 | 2.16 | 4.92 | 30.27 | |||
ICPT | 2.96 | (0.84) | 0.00 | (1.25) | 0.00 | 5.23 | 38.17 | |||
TGTX | 2.79 | 0.25 | 0.09 | 0.22 | 3.30 | 7.34 | 24.51 | |||
TERN | 3.39 | (0.43) | 0.00 | (0.29) | 0.00 | 5.68 | 34.09 | |||
HEPA | 3.90 | (0.11) | (0.02) | 0.01 | 4.43 | 8.06 | 33.54 | |||
VKTX | 3.51 | (0.39) | 0.00 | (0.18) | 0.00 | 6.24 | 34.61 | |||
AXSM | 1.68 | 0.07 | 0.02 | 0.21 | 1.87 | 4.10 | 13.67 | |||
MCRB | 4.49 | 0.06 | 0.00 | 0.39 | 5.43 | 10.00 | 26.87 | |||
MREO | 2.62 | (0.41) | 0.00 | (0.18) | 0.00 | 5.14 | 19.32 | |||
PDSB | 3.22 | (0.85) | 0.00 | (0.42) | 0.00 | 5.77 | 31.83 |
View ImmunoGen Related Equities
Risk & Return | Correlation |
ImmunoGen Corporate Management
Daniel JD | VP Officer | Profile | |
Susan Altschuller | VP CFO | Profile | |
MMSc MD | VP Officer | Profile | |
Lauren MBA | Senior Officer | Profile | |
Renee Lentini | VP Officer | Profile | |
Stacy Coen | Sr Officer | Profile | |
Audrey Bergan | Senior Officer | Profile |
Still Interested in ImmunoGen?
Investing in delisted delisted stocks can be risky, as the stock is no longer traded on a public exchange and can therefore be difficult to sell. Delisting typically occurs when a company has failed to meet exchange requirements or has been acquired. Before investing, it's important to thoroughly research the company, including its financial health and prospects for the future, as well as the reasons for its delisting. Additionally, it may be difficult to find accurate and up-to-date information on the company and its stock.